Human gm-csf antigen binding proteins
AssigneeAmgen Inc.
InventorsJacqueline A. Kirchner, Kenneth A. Brasel, Kara Olson, Jose Carlos Escobar, Dauphine Barone
Life of this patent
Estimating the term…
Abstract
Antigen binding proteins that bind to human GM-CSF protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of GM-CSF to GM-CSFR, inhibit GM-CSF-induced proliferation and signaling of myeloid lineage cell lines and inhibit GM-CSF-induced activation of human monocytes.
Claims37
An isolated antigen binding protein that binds GM-CSF, comprising:
- A) one or more heavy chain complementary determining regions (CDRHs) selected from the group consisting of:
- (i) a CDRH1 selected from the group consisting of SEQ ID NO:
- 10, 22, 70 94 and 142;
- (ii) a CDRH2 selected from the group consisting of SEQ ID NO:
- 11, 23, 28, 35, 47, 59, 71, 95, 106, 119 and 143;
- (iii) a CDRH3 selected from the group consisting of SEQ ID NO:
- 12, 24, 36, 48, 60, 72, 83, 96, 108, 120, 132, and 144;
- and
- (iv) a CDRH of (i), (ii) and (iii) that contains one or more amino acid substitutions, deletions or insertions of no more than 4 amino acids;
- B) one or more light chain complementary determining regions (CDRLs) selected from the group consisting of:
- (i) a CDRL1 selected from the group consisting of SEQ ID NO:
- 4, 16, 30, 40, 52, 64, 88, 100, 107, 112, 118, 124, 125 and 136;
- (ii) a CDRL2 selected from the group consisting of SEQ ID NO:
- 5, 17, 29, 34, 41, 65, 77, 101, 113, 130, 131 and 137;
- (iii) a CDRL3 selected from the group consisting of SEQ ID NO:
- 6, 18, 42, 46, 66, 78, 84, 89, 90, 102, 114, 126, and 138;
- and
- (iv) a CDRL of (i), (ii) and (iii) that contains one or more amino acid substitutions, deletions or insertions of no more than 4 amino acids;
- or
- C) one or more heavy chain CDRHs of A) and one or more light chain CDRLs of B).
An isolated antigen binding protein that binds GM-CSF, wherein said antigen binding protein comprises:
- A) one or more heavy chain CDRs (CDRHs) selected from the group consisting of:
- (i) a CDRH1 selected from the group consisting of SEQ ID NO:
- 10, 22, 70 94 and 142;
- (ii) a CDRH2 selected from the group consisting of SEQ ID NO:
- 11, 23, 28, 35, 47, 59, 71, 95, 106, 119 and 143;
- (iii) a CDRH3 selected from the group consisting of SEQ ID NO:
- 12, 24, 36, 48, 60, 72, 83, 96, 108, 120, 132, and 144;
- B) one or more light chain CDRs (CDRLs) selected from the group consisting of:
- (i) a CDRL1 selected from the group consisting of SEQ ID NO:
- 4, 16, 30, 40, 52, 64, 88, 100, 107, 112, 118, 124, 125 and 136;
- (ii) a CDRL2 selected from the group consisting of SEQ ID NO:
- 5, 17, 29, 34, 41, 65, 77, 101, 113, 130, 131 and 137;
- (iii) a CDRL3 selected from the group consisting of SEQ ID NO:
- 6, 18, 42, 46, 66, 78, 84, 89, 90, 102, 114, 126, and 138;
- or
- C) one or more heavy chain CDRHs of A) and one or more light chain CDRLs of B).
Dependencies are inferred from the claim text.